BAZ2B
protein-codingbromodomain adjacent to zinc finger domain 2B, the group of Methyl-CpG binding domain containing|PHD finger proteins|Bromodomain containing
Gene summary
This gene belongs to the bromodomain gene family. Members of this gene family encode proteins that are integral components of chromatin remodeling complexes. The encoded protein showed strong preference for the activating H3K14Ac mark in a histone peptide screen, suggesting a potential role in transcriptional activation. This gene may be associated with susceptibility to sudden cardiac death (SCD). [provided by RefSeq, Aug 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~301.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
The *BAZ2B* gene is a member of the BAZ gene family that encodes integral components of chromatin remodeling complexes that modulate transcription, DNA replication, and DNA repair. *BAZ2B* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2020 (Scott et al., PMID:31999386). Clinical features in reported probands include neurodevelopmental disorders such as intellectual disability, developmental delay, and autism spectrum disorder. Other features are highly variable, reported only in one or few individuals. At least 24 unique variants (7 nonsense, 3 frameshift, 12 missense, 2 large deletions) have been reported in the literature (PMIDs: 25363768, 28135719, 28554332, 28867142, 31398340, 31981491, 31999386, 33057194). In 26 unrelated probands reported, 19 (73%) variants were *de novo*, 1 inherited from an unaffected parent, and the rest of unknown inheritance. While *BAZ2B* is intolerant to truncating variants (pLI 0.98, gnomAD v2.1.1), it is not significantly constrained for missense variants (Z = 1.33). Thus, in the absence of functional evidence of pathogenicity, missense variants were not scored. Probands with other potential genetic explanations for their neurodevelopmental phenotypes, deletions of *BAZ2B* that encompass additional genes, mosaic variants at low allele frequencies, and truncating variants reported in gnomAD or inherited from reportedly unaffected parents were also not scored since the impact of *BAZ2B* on the phenotype is unclear. Six truncating *de novo* variants in 6 probands from 5 publications (PMIDs: 25363768, 28554332, 31981491, 31999386, 33057194) are included in this curation. Although the total points contained within this curation meet the threshold for a “Moderate” classification, the expert panel elected to downgrade the overall classification to “Limited” while we await additional human genetic evidence. In summary, there is limited evidence at this time to support the relationship between *BAZ2B* and autosomal dominant complex neurodevelopmental disorder. Additional studies are required to verify this gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on October 19, 2022 (SOP Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BAZ2B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_013450.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 27 | 4 | 33 | ||
| missense | 2 | 2 | 392 | 65 | 3 | 464 |
| nonsense | 2 | 2 | 8 | 1 | 13 | |
| start loss | 1 | 1 | ||||
| frameshift | 3 | 3 | 7 | 13 | ||
| splice donor/acceptor (+/-2bp) | 4 | 8 | 12 | |||
| Total | 7 | 12 | 417 | 93 | 7 | 536 |
Highest pathogenic variant AF is 0.000006580333
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_038478.2 | 35 | MANE Select | |
| Ensembl | ENSP00000376534.2 | 35 | MANE Select | |
| RefSeq | NP_001276904.1 | 34 | Standard | |
| RefSeq | NP_001316786.1 | 35 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- chromatin remodeling
- regulation of transcription by RNA polymerase II
Molecular Function
- DNA binding
- protein binding
- metal ion binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000392783
- Coding exons
- 35
- Length
- 297714
- Individuals with no LoFs
- 124982
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 44
- Defined
- 125026
- p
- 0.000176
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.33 | 971 | 1.10e+3 | 0.887 | 0.0000550 | 14209 |
| Missense (PolyPhen) | 236 | 338.46 | 0.69728 | 4349 | ||
| Synonymous | 0.346 | 371 | 380 | 0.977 | 0.0000188 | 4061 |
| Loss of Function | 7.73 | 22 | 109 | 0.201 | 0.00000604 | 1381 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00039 | 0.00026 | rare |
| Latino/Admixed American | 0.000087 | 0.000058 | rare |
| Ashkenazi Jewish | 0.00070 | 0.00040 | rare |
| East Asian | 0.00017 | 0.00016 | rare |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00016 | 0.00016 | rare |
| South Asian | 0.000099 | 0.000098 | rare |
| Other | 0.00069 | 0.00066 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May play a role in transcriptional regulation interacting with ISWI.;
Recessive Scores
- pRec
- 0.0949
Intolerance Scores
- LoFtool
- 0.244
- RVIS EVS
- -1.42
- RVIS percentile EVS
- 4.06
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.830
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | High | Medium | High |
| Cancer | High | High | High |